JP2013519083A5 - - Google Patents

Download PDF

Info

Publication number
JP2013519083A5
JP2013519083A5 JP2012551689A JP2012551689A JP2013519083A5 JP 2013519083 A5 JP2013519083 A5 JP 2013519083A5 JP 2012551689 A JP2012551689 A JP 2012551689A JP 2012551689 A JP2012551689 A JP 2012551689A JP 2013519083 A5 JP2013519083 A5 JP 2013519083A5
Authority
JP
Japan
Prior art keywords
flc
infection
amount
light chain
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012551689A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013519083A (ja
JP5818818B2 (ja
Filing date
Publication date
Priority claimed from GBGB1001950.3A external-priority patent/GB201001950D0/en
Application filed filed Critical
Publication of JP2013519083A publication Critical patent/JP2013519083A/ja
Publication of JP2013519083A5 publication Critical patent/JP2013519083A5/ja
Application granted granted Critical
Publication of JP5818818B2 publication Critical patent/JP5818818B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012551689A 2010-02-05 2011-02-04 感染症予後診断アッセイ Active JP5818818B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1001950.3 2010-02-05
GBGB1001950.3A GB201001950D0 (en) 2010-02-05 2010-02-05 Infection prognostic assay
PCT/GB2011/050197 WO2011095820A1 (en) 2010-02-05 2011-02-04 Infection prognostic assay

Publications (3)

Publication Number Publication Date
JP2013519083A JP2013519083A (ja) 2013-05-23
JP2013519083A5 true JP2013519083A5 (enExample) 2014-04-10
JP5818818B2 JP5818818B2 (ja) 2015-11-18

Family

ID=42082582

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012551689A Active JP5818818B2 (ja) 2010-02-05 2011-02-04 感染症予後診断アッセイ
JP2012551687A Active JP5818817B2 (ja) 2010-02-05 2011-02-04 がん予後診断アッセイ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012551687A Active JP5818817B2 (ja) 2010-02-05 2011-02-04 がん予後診断アッセイ

Country Status (6)

Country Link
US (2) US20130149792A1 (enExample)
EP (1) EP2531857B1 (enExample)
JP (2) JP5818818B2 (enExample)
CN (2) CN102859361B (enExample)
GB (1) GB201001950D0 (enExample)
WO (1) WO2011095820A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2519564A (en) * 2013-10-24 2015-04-29 Shared Band Ltd Multicast transmission over bonded broadband
EP3175001B1 (en) * 2014-07-30 2021-02-10 Mor Research Applications Ltd. Prognostic methods and systems of treatment for acute lymphoblastic leukemia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792529A (en) * 1985-10-18 1988-12-20 University Of Rochester Immunoassay of free kappa light chains for the detection of multiple sclerosis
IT1216698B (it) * 1988-04-01 1990-03-08 New Scient Co Spa Metodo per la determinazione della presenza di catene leggere libere in campioni di urina, complesso di preparati per l'esecuzione del metodo, e relativo reagente.
ES2233980T3 (es) 1995-11-03 2005-06-16 The Binding Site Limited Produccion de anticuerpos.
US6322788B1 (en) * 1998-08-20 2001-11-27 Stanley Arthur Kim Anti-bacterial antibodies and methods of use
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein
US20090082304A1 (en) * 2004-11-12 2009-03-26 Northwestern University Methods of Treating Hematological Malignancies with Nucleoside Analog Drugs
GB0501741D0 (en) * 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
JP4950879B2 (ja) * 2005-04-12 2012-06-13 松森  昭 心疾患診断用バイオマーカー及びその利用
JP2007292661A (ja) * 2006-04-26 2007-11-08 Akira Matsumori 活動性心筋炎の検出方法および検出試薬
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain

Similar Documents

Publication Publication Date Title
Guery et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis
Bruns et al. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia
Jitpean et al. Increased concentrations of Serum amyloid A in dogs with sepsis caused by pyometra
Mauri et al. Alveolar pentraxin 3 as an early marker of microbiologically confirmed pneumonia: a threshold-finding prospective observational study
Ueda et al. Diagnostic accuracy of the E-plate serum antibody test kit in detecting Helicobacter pylori infection among Japanese children
JP2012509477A5 (enExample)
Binns et al. Development and validation of an ELISA to detect antibodies to Corynebacterium pseudotuberculosis in ovine sera
JP2011085586A5 (enExample)
Zhang et al. Detection of sepsis in patient blood samples using CD64 expression in a microfluidic cell separation device
Contenti et al. Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy
Yu et al. Distinction between bacterial and viral infections by serum measurement of human neutrophil lipocalin (HNL) and the impact of antibody selection
CN103562725B (zh) 川崎病的诊断标志物和治疗靶点
Weh et al. Discriminatory potential of C-reactive protein, cytokines, and fecal markers in infectious gastroenteritis in adults
Wu et al. Procalcitonin as a diagnostic biomarker for septic shock and bloodstream infection in burn patients from the Formosa Fun Coast dust explosion
Woodhouse et al. Harnessing the host response for precision infectious disease diagnosis
JP2013519083A5 (enExample)
Teng et al. Outcome prediction using the Mortality in Emergency Department Sepsis score combined with procalcitonin for influenza patients
CA2955214A1 (en) Diagnosis and treatment of kawasaki disease
CN104808003B (zh) 肺结核疗效评价试剂盒及其应用
Dal Negro et al. A two-stage logistic model based on the measurement of pro-inflammatory cytokines in bronchial secretions for assessing bacterial, viral, and non-infectious origin of COPD exacerbations
JP2010014586A5 (enExample)
JP2013519082A5 (enExample)
Erturk et al. Serum resistin levels may be new prognostic factor of Crimean-Congo hemorrhagic fever
Azman et al. C-reactive Protein, Albumin, Urea, CRP/Albumin Ratio, and Urea/Albumin ratio: A retrospective evaluation in COVID-19 patients
Chen et al. Parainfluenza infection is associated with Henoch-Schönlein purpura in children